Safety Problem Plus GMP Warnings Equal Increased Likelihood Of DoJ Action

Triceuticals agrees with DoJ to a consent decree of permanent injunction against distributing adulterated supplements. DoJ says a consumer of a Triceuticals product experienced headache, confusion and kidney failure resulting in hospitalization due to vitamin D toxicity.

Ignoring good manufacturing practices warnings landed Triceuticals Inc. in hot water with FDA, and a consumer’s kidney failure associated with a product containing “high levels of vitamin D” helped catch the Department of Justice’s attention.

Triceuticals and its president, Liqun Zhang, agreed to a consent decree permanently preventing them from manufacturing and distributing adulterated dietary supplements, DoJ announced July 9. The decree entered in New...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from North America